Follow
Dr.Prakash Muthudoss
Dr.Prakash Muthudoss
Start-up
Verified email at oncogenpharma.com
Title
Cited by
Cited by
Year
Iso-structurality induced solid phase transformations: a case study with lenalidomide
R Chennuru, P Muthudoss, RS Voguri, S Ramakrishnan, P Vishweshwar, ...
Crystal Growth & Design 17 (2), 612-628, 2017
242017
In situ metastable form: a route for the generation of hydrate and anhydrous forms of ceritinib
R Chennuru, RT Koya, P Kommavarapu, SV Narasayya, P Muthudoss, ...
Crystal Growth & Design 17 (12), 6341-6352, 2017
152017
Preliminary studies on unusual polymorphs of thymine: Structural comparison with other nucleobases
R Chennuru, P Muthudoss, S Ramakrishnan, AB Mohammad, RRC Babu, ...
Journal of Molecular Structure 1120, 86-99, 2016
132016
Micronization and agglomeration: understanding the impact of API particle properties on dissolution and permeability using solid state and biopharmaceutical “toolbox”
P Muthudoss, P Khullar
Journal of Pharmaceutical Innovation 16, 136-151, 2021
92021
Quantitative microscopy: particle size/shape characterization, addressing common errors using ‘analytics continuum’approach
D Saravanan, P Muthudoss, P Khullar, AR Venis
Journal of Pharmaceutical Sciences 110 (2), 833-849, 2021
92021
Topologically directed confocal Raman imaging (TD-CRI): Advanced Raman imaging towards compositional and micromeritic profiling of a commercial tablet components
P Muthudoss, S Kumar, EYC Ann, KJ Young, RLR Chi, R Allada, ...
Journal of pharmaceutical and biomedical analysis 210, 114581, 2022
82022
A new febuxostat-telmisartan drug-drug cocrystal for gout-hypertension combination therapy
T Ganesan, P Muthudoss, RS Voguri, S Ghosal, EYC Ann, J Kwok, ...
Journal of pharmaceutical sciences 111 (12), 3318-3326, 2022
72022
Machine learning–enabled NIR spectroscopy. Part 2: workflow for selecting a subset of samples from publicly accessible data
H Ali, P Muthudoss, M Ramalingam, L Kanakaraj, A Paudel, G Ramasamy
AAPS PharmSciTech 24 (1), 34, 2023
62023
Artificial intelligence (AI) in drug product designing, development, and manufacturing
S Chaudhary, P Muthudoss, T Madheswaran, A Paudel, V Gaikwad
A handbook of artificial intelligence in drug delivery, 395-442, 2023
62023
Machine learning-enabled NIR spectroscopy in assessing powder blend uniformity: clear-up disparities and biases induced by physical artefacts
P Muthudoss, I Tewari, RLR Chi, KJ Young, EYC Ann, DNS Hui, OY Khai, ...
AAPS PharmSciTech 23 (7), 277, 2022
52022
Vendor qualification: Utilization of solid state characterization “Toolbox” to assess material variability for active pharmaceutical ingredient
D Saravanan, P Muthudoss, P Khullar, A Rosevenis
Journal of Applied Pharmaceutical Science 9 (9), 001-009, 2019
42019
ML in drug delivery—current scenario and future trends
P Muthudoss, H Ali, G Ramasamy, R Allada, E Fink, V Kalaiselvan, ...
Advances in Drug Delivery Systems for Healthcare: From concept to clinic, 9 …, 2024
2024
Machine Learning-Enabled NIR Spectroscopy. Part 3: Hyperparameter by Design (HyD) Based ANN-MLP Optimization, Model Generalizability, and Model Transferability
H Ali, P Muthudoss, C Chauhan, I Kaliappan, D Kumar, A Paudel, ...
AAPS PharmSciTech 24 (8), 254, 2023
2023
Comparison of In Vitro Phosphate-Binding Studies of Sevelamer Carbonate Using Incubator Shaker and USP Dissolution Apparatus II
NS Tibon, R Allada, S Vakkala, P Muthudoss, S Syed
DISSOLUTION TECHNOLOGIES 29 (2), 78-84, 2022
2022
Pregelatinized Starch: Variability in Gelatinization and its Influence on Product Performance
D Saravanan, P Muthudoss, P Khullar
International Journal of Research in Pharmaceutical Sciences 12 (1), 141-149, 2021
2021
Unusual polymorphs of thymine
SK Nayak, R Chennuru, P Muthudoss, S Ramakrishnan, AB Mohammad, ...
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES 70, C1412-C1412, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–16